MEDIOS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.26 EUR | +1.13% |
|
-0.70% | -10.09% |
| Mar. 27 | Medios AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 18 | Medios AG Provides Earnings Guidance for the Year 2024 | CI |
ETFs positioned on Medios AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.19% | 17 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Sector
Pharmaceuticals
Calendar
2024-05-06
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.26
EUR
Average target price
34.75
EUR
Spread / Average Target
+143.69%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.09% | 362M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- ILM1 Stock
- Funds and ETFs Medios AG
